共 11 条
Dual Therapeutic Effects of C-10068, a Dextromethorphan Derivative, Against Post-Traumatic Nonconvulsive Seizures and Neuroinflammation in a Rat Model of Penetrating Ballistic-Like Brain Injury
被引:12
|作者:
Lu, Xi-Chun May
[1
]
Shear, Deborah A.
[1
]
Graham, Philip B.
[2
]
Bridson, Gary W.
[2
]
Uttamsingh, Vinita
[2
]
Chen, Zhiyong
[1
]
Leung, Lai Yee
[1
]
Tortella, Frank C.
[1
]
机构:
[1] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD 20910 USA
[2] Concert Pharmaceut Inc, Lexington, MA USA
关键词:
C-10068;
dextromethorphan;
EEG;
neuroinflammation;
nonconvulsive seizures;
penetrating brain injury;
METHYL-D-ASPARTATE;
KAINATE-INDUCED SEIZURES;
NEURONAL DAMAGE;
FOCAL ISCHEMIA;
ION CHANNELS;
DEXTRORPHAN;
SIGMA;
PHENYTOIN;
NEUROPROTECTION;
DEFICITS;
D O I:
10.1089/neu.2014.3766
中图分类号:
R4 [临床医学];
学科分类号:
1002 ;
100602 ;
摘要:
Post-traumatic seizures can exacerbate injurious outcomes of severe brain trauma, yet effective treatments are limited owing to the complexity of the pathology underlying the concomitant occurrence of both events. In this study, we tested C-10068, a novel deuterium-containing analog of (+)-N-methyl-3-ethoxymorphinan, in a rat model of penetrating ballistic-like brain injury (PBBI) and evaluated the effects of C-10068 on PBBI-induced nonconvulsive seizures (NCS), acute neuroinflammation, and neurofunctional outcomes. NCS were detected by electroencephalographic monitoring. Neuroinflammation was evaluated by immunohistochemical markers, for example, glial fibrillary acidic protein and major histocompatibility complex class I, for activation of astrocytes and microglia, respectively. Neurofunction was tested using rotarod and Morris water maze tasks. Three infusion doses of C-10068 (1.0, 2.5, and 5.0mg/kg/hx72h) were tested in the antiseizure study. Neuroinflammation and neurofunction were evaluated in animals treated with 5.0mg/kg/hx72h C-10068. Compared to vehicle treatment, C-10068 dose dependently reduced PBBI-induced NCS incidence (40-50%), frequency (20-70%), and duration (30-82%). The most effective antiseizure dose of C-10068 (5.0mg/kg/hx72h) also significantly attenuated hippocampal astrocyte activation and perilesional microglial reactivity post-PBBI. Within C-10068-treated animals, a positive correlation was observed in reduction in NCS frequency and reduction in hippocampal astrocyte activation. Further, C-10068 treatment significantly attenuated astrocyte activation in seizure-free animals. However, C-10068 failed to improve PBBI-induced motor and cognitive functions with the dosing regimen used in this study. Overall, the results indicating that C-10068 exerts both potent antiseizure and antiinflammatory effects are promising and warrant further investigation.
引用
收藏
页码:1621 / 1632
页数:12
相关论文